PTC Therapeutics Inc. buy UBS Group AG
Start price
03.12.24
/
50%
€49.60
Target price
03.12.25
€67.48
Performance (%)
28.02%
End price
04.12.25
€63.50
Summary
This prediction ended on 04.12.25 with a price of €63.50. The BUY prediction by UBS_Group_AG finished with a performance of 28.02%. UBS_Group_AG has a follow-up prediction for PTC Therapeutics Inc. where he still thinks PTC Therapeutics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | -4.310% | -4.310% | 11.446% |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% |
Comments by UBS_Group_AG for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at UBS Group AG from $47.00 to $71.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
29.07.25
29.07.25
€68.98
29.07.26
29.07.26
26.15%
11:03
11:03
Stopped prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.00
26.08.24
26.08.24
€42.11
26.08.25
26.08.25
34.19%
27.08.25
27.08.25